Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insider Trading: Coliseum Capital Buys More $LHCG

Christopher Shackelton and Adam Gray’s Coliseum Capital filed Form 4 for its insider purchases in LHC Group, Inc. (LHCG). According to the filings, Coliseum Capital bought totally 103 thousand shares in LHCG on November 4th, 7th and 8th, at the price near $14 per share. Coliseum Capital now takes 1.98 million shares in LHCG after the transaction, corresponding to a 10.6% passive stake ownership. In the third quarter Coliseum Capital has boosted its position by 239%, since it reported 829 thousand LHCG shares in its previous 13F filing. Now LHCG is trading at $13.89, and has already dropped by 54% in 2011.

LHC Group, Inc. (NASDAQ:LHCG)

Six other hedge funds were also bullish about LHCG in the second quarter. Chuck Royce’s Royce & Associates took the largest stake among the hedge funds, with 1.92 million shares at that time. Jim Simons’ Renaissance Technologies reported 77 thousand shares, up by 164% from Q1.

Coliseum Capital Management is a privately owned hedge fund. The firm invests in public equity markets. The firm is based in New York City, New York. The firm has a portfolio of $107 million, mainly invested in Services, Financial, and Healthcare sector.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals in the United States. The company operates two segments: home-based services and facility-based services. The company was founded in 1994 and is based in Lafayette, Louisiana.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!